VICO — Vicore Pharma Holding AB Share News
0.000.00%
Last trade - 00:00- SEK2.73bn
- SEK1.83bn
- SEK3.82m
Brief: Vicore Reports Positive Results From Pulmonary Fibrosis Study
Brief: Vicore Confirms IPF Development Program On Track, Provides Updates
Brief: Vicore Appoints Bertil Lindmark Chief Medical Officer
Brief: Vicore Pharma Holding Q3 Loss Narrows To SEK 63.6 Million
Brief: Vicore Pharma Q3 EBIT SEK -65.1 Million
Brief: Vicore Provides Update Regarding Phase 1 Study Of C106
Brief: Vicore Pharma Q2 EBIT SEK -69.8 Million
Brief: Vicore Reports Data From Endopat Exploratory Trial
Brief: Vicore Announces Appointment Of Ahmed Mousa As CEO
Brief: Vicore CEO Retires, Company Starts Recruitment Process
Brief: Vicore Pharma Raises SEK 500 Mln Through Directed Share Issues
Brief: Vicore Further Strengthens Patent Protection For C21
Brief: Vicore Obtains New Patent Protection For C21 In The U.S.
Brief: Vicore Pharma Reports Q1 EBIT of SEK -66.1 Million
Brief: Vicore Pharma Posts Q4 Operating Loss of SEK 63 Million
Brief: Vicore Pharma Holding Proposes No Dividend Be Paid For 2022
Brief: Vicore Says Has Carried Out Directed Share Issue Of 10 Mln Shares At Subscription Price Of Sek 20 Per Share, Raising Gross Proceeds Of Sek 200 Mln
Brief: Vicore Intends To Carry Out A Directed Share Issue
Brief: Vicore Pharma Holding Q3 Operating Loss Narrows To SEK 69.7 Mln